This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Determine the safety and tolerability of orally administered Dimebon during dosage escalation in subjects with mild to moderate Huntington's disease.
Showing the most recent 10 out of 1825 publications